Encompass Health Files 8-K for Regulation FD Disclosure

Ticker: EHC · Form: 8-K · Filed: Feb 27, 2024 · CIK: 785161

Sentiment: neutral

Topics: regulation-fd, corporate-governance, disclosure

TL;DR

**Encompass Health just filed an 8-K for Regulation FD, meaning they're making a prior non-public disclosure public.**

AI Summary

Encompass Health Corporation filed an 8-K on February 27, 2024, under Regulation FD Disclosure. This filing indicates that the company, incorporated in Delaware with IRS Employer Identification No. 63-0860407, is providing information to the public, likely related to a non-public disclosure of material information. The filing does not contain specific financial figures or events but serves as a formal notification of a disclosure event.

Why It Matters

This filing ensures that Encompass Health Corporation is transparent with investors by publicly disclosing information that may have been selectively shared, maintaining fair and equal access to material information.

Risk Assessment

Risk Level: low — The filing is a standard regulatory disclosure and does not inherently indicate a negative or positive event without further context.

Key Players & Entities

FAQ

What is the purpose of Encompass Health Corporation's 8-K filing on February 27, 2024?

The 8-K filing by Encompass Health Corporation on February 27, 2024, is for Regulation FD Disclosure, indicating the public disclosure of material non-public information.

What is the state of incorporation for Encompass Health Corporation?

Encompass Health Corporation is incorporated in Delaware.

What is the IRS Employer Identification Number for Encompass Health Corporation?

The IRS Employer Identification Number for Encompass Health Corporation is 63-0860407.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on February 27, 2024.

What is the business address of Encompass Health Corporation?

The business address of Encompass Health Corporation is 9001 Liberty Parkway, Birmingham, Alabama 35242.

Filing Stats: 644 words · 3 min read · ~2 pages · Grade level 14.2 · Accepted 2024-02-27 17:09:56

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

ITEM 7.01. Regulation FD Disclosure. On February 21, 2024, Encompass Health Corporation (the "Company") received notice from Change Healthcare, a subsidiary of UnitedHealth Group that acts as an intermediary for processing our payment claims for all payors, of a cybersecurity incident affecting certain of Change Healthcare's information technology systems. In response to the incident, both the Company and Change Healthcare severed those business service connections between the Company's systems and Change Healthcare's. Since receiving notice from Change Healthcare, the Company has been conducting forensics on its systems, including searching for known indicators of compromise. To date, the Company has not identified any compromise or unauthorized access of its systems or networks. The Change Healthcare incident has not affected the Company's operations, except its submission of payment claims. The Company is still receiving referrals and admitting, caring for, and discharging patients in the ordinary course. In the event the Change Healthcare service is not restored in a timely fashion, the Company may experience payment collection delays as it turns to alternative channels to submit claims. At this time, Change Healthcare has not provided an estimated service restoration timeline. As of the date of this Current Report on Form 8-K, the Company has not determined that the Change Healthcare cybersecurity incident is material to the Company. The information contained herein is being furnished pursuant to Item 7.01 of Form 8-K, "Regulation FD Disclosure." This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The furnishing of this information will not be deemed an admission as to the materiali

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. ENCOMPASS HEALTH CORPORATION By: / S / Patrick Darby Name: Patrick Darby Title: Executive Vice President, General Counsel and Secretary Dated: February 27, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing